Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3) [Phase 3]
A Phase 3 efficacy trial evaluating new treatment schedules in treatment-naive patients with genotype 3 hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients [NA]
This clinical trial update concerns a study aimed at preventing depression in patients co-infected with HIV and Hepatitis C who have substan…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C [Phase 4]
Phase 4 clinical trial evaluating pegylated interferon plus ribavirin in active and past intravenous drug users with hepatitis C has complet…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy [Phase 2]
A Phase 2 rollover trial update for Hepatitis C patients who were in the control arms of VX06-950-106, VX05-950-104 and VX05-950-104EU studi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV) [Phase 3]
A Phase 3 study of telaprevir in combination with Pegasys and Copegus in treatment-naive genotype 1 hepatitis C patients completed, with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) [Phase 2]
This clinical trial update reports the completion of the Phase 2 PROVE3 study evaluating telaprevir in combination with peginterferon alfa-2…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C [Phase 2]
A Phase 2 study evaluating VX-950 (telaprevir) in combination with pegylated interferon alfa-2a, with or without ribavirin (Copegus) for chr…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C [Phase 2]
Phase 2 study evaluating VX-950 (telaprevir) in combination with Pegasys and Copegus for chronic hepatitis C has completed and posted result…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response [Phase 3]
Phase 3 trial evaluating 24- or 48-week telaprevir-based regimens in treatment-naïve genotype 1 Hepatitis C patients achieving extended rapi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users [Phase 4]
Phase 4 clinical trial comparing raltegravir to a protease inhibitor in treatment-naïve HIV/Hepatitis C drug users. The update provides no r…
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: MRKAd5 HIV-1 Gag Vaccine (V520) in Subjects With Chronic Hepatitis C (V520-022) (COMPLETED) [Phase 1]
Phase 1 trial of MRKAd5 HIV-1 Gag Vaccine (V520) in adults with chronic hepatitis C has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: 14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response [Phase 3]
Phase 3 trial comparing 14-week versus 24-week hepatitis C treatment in genotype 2/3 patients with rapid virological response has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects [Phase 2]
A Phase 2 multiple ascending dose study of BMS-650032 in chronic hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3 [Phase 4]
A Phase 4 trial evaluating low-dose peginterferon in combination with ribavirin to treat chronic hepatitis C in patients infected with HCV g…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED) [Phase 3]
Phase 3 study evaluating boceprevir in adults with chronic hepatitis C genotype 1 who failed prior peginterferon/ribavirin therapy has been …
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523) [Phase 2]
Phase 2 trial results for SCH 503034 in previously untreated genotype 1 chronic hepatitis C show safety and efficacy outcomes, with the stud…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a plus ribavirin for treating Hepatitis C in HIV-infected patients completed, with resul…
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED) [Phase 3]
A Phase 3 trial evaluating boceprevir in previously untreated patients with chronic hepatitis C genotype 1; results on safety and efficacy h…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Chiron Corp HCV E1/E2 Vaccine [Phase 1]
Phase 1 study of Chiron's Hepatitis C E1/E2 vaccine sponsored by NIAID has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus [Phase 1]
Phase 1 repeat-dose trial of bavituximab in patients co-infected with hepatitis C and HIV has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Drug-Drug Interaction Study Between Telaprevir and Buprenorphine [Phase 1]
Phase 1 drug-drug interaction study between telaprevir and buprenorphine has been completed, evaluating safety and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment [Phase 1]
This document reports an update from a Phase 1b study of Omega DUROS in patients with chronic hepatitis C who relapsed after prior treatment…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance [Phase 1]
Pfizer completed a Phase 1 drug interaction study to evaluate the interaction between filibuvir and methadone in individuals on chronic meth…
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C [Phase 4]
A Phase 4 clinical trial update examining how antiviral therapy for chronic hepatitis C affects bone mineral density and metabolism.
-
CLINICAL_TRIALS research · 2011-05-26Clinical Trial Update: Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography
A clinical trial exploring whether real-time tissue elastography can predict liver cancer risk in patients with chronic hepatitis B or C.